You are here: Home » News-ANI » International » World
Business Standard

Trump calls for anti-malaria drug to be used for COVID19 treatment despite caution from health expert

Topics
Health Medical Pharma

ANI  |  US 

United States President Donald Trump has called for an anti-malaria drug to be used to treat the coronavirus, despite being cautioned by his health expert Dr. Anthony S. Fauci saying that evidence for its effectiveness was so far "anecdotal".

He tweeted, "HYDROXYCHLOROQUINE & AZITHROMYCIN, taken together, have a real chance to be one of the biggest game-changers in the history of medicine. The FDA has moved mountains - Thank You! Hopefully, they will BOTH (H works better with A, International Journal of Antimicrobial Agents)....."

The nation's leading infectious disease expert, Dr Anthony S. Fauci, explaining that there was only anecdotal evidence that the drugs, chloroquine, and hydroxychloroquine, may be effective, the New York Times reported.

No drug has been approved to treat the new coronavirus, and doctors around the have been desperately administering an array of medicines in search of something to help patients, especially those who are severely ill.

The malaria drugs, chloroquine, and hydroxychloroquine are among the remedies that have been tried in several countries as the virus has spread around the

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, March 21 2020. 23:14 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU